NYMIVI
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97236483
- Registration number
- 7868369
- Mark type
- Stylized text
- Filed
- 25 Jan 2022
- Published for opposition
- 13 Dec 2022
- Registered
- 15 Jul 2025
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating subarachnoid hemorrhage
Owner
- GRACE THERAPEUTICS U.S., INC., PRINCETON, NJ, US
- GRACE THERAPEUTICS U.S., INC., PRINCETON, NJ, US
- Acasti Pharma US Inc., Princeton, NJ, US
- Acasti Pharma US Inc., North Brunswick, NJ, US
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Jun 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 May 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Mar 2025 — USE AMENDMENT FILED
- 30 May 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Mar 2025 — TEAS STATEMENT OF USE RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Nov 2024 — SOU EXTENSION 4 GRANTED
- 20 Nov 2024 — SOU EXTENSION 4 FILED
- 20 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Nov 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 15 Nov 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 15 Nov 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED